首页 > 市场调查报告书 > 医疗设备

导管心血管设备

经导管栓塞和闭塞装置市场规模、份额和成长分析（按类型、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902460

经导管栓塞和闭塞装置市场规模、份额和成长分析（按类型、应用、最终用途和地区划分）－2026-2033年产业预测

Transcatheter Embolization and Occlusion Devices Market Size, Share, and Growth Analysis, By Type (Coil, And Non-coil), By Application (Neurology, Oncology), By End-use, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，经导管栓塞和闭塞装置市场规模将达到 51.7 亿美元，到 2025 年将达到 55.4 亿美元，到 2033 年将达到 96.7 亿美元，预测期（2026-2033 年）的复合年增长率为 7.2%。

经导管栓塞和闭塞器械的全球市场持续发展，这主要得益于人口老化、有利的报销政策以及保险覆盖范围的扩大等因素，这些因素正推动医疗机构采用相关技术。儘管监管挑战和竞争构成一定障碍，但该市场仍蕴藏着巨大的成长机会，尤其是在应对多种疾病方面。亚太和非洲等新兴地区为製造商提供了尚未开发的市场潜力，这得益于器械设计和诊断成像技术的创新。医疗专业人员、製造商和研究机构之间的合作将推动技术进步和市场扩张。此外，向患者和医疗机构普及微创治疗的益处至关重要，因为人工智慧 (AI) 和数据分析的应用可以提高医疗管理的精准性和个人化程度，从而进一步刺激市场需求。

推动经导管栓塞和闭塞装置市场发展的因素

癌症、肝病和心血管疾病等慢性疾病的日益流行，推动了对微创医疗干预（例如经导管栓塞和闭塞术 (TEO)）的需求。这些装置在治疗癌症方面特别有效，癌症是全球主要的死亡原因之一，尤其适用于难治性肿瘤。随着栓塞疗法日益被认可为有效的安宁疗护选择，医疗机构越来越多地采用 TEO 装置来改善病患预后。医疗机构对 TEO 装置的日益普及，显着推动了经导管栓塞和闭塞装置的市场成长。

经导管栓塞及闭塞装置市场的限制因素

血液透析技术及相关设备的高昂成本严重阻碍了经导管栓塞和封堵装置的广泛应用，尤其是在发展中地区。诸如药物释放型微球和放射性栓塞试剂盒等先进装置，其价格本身就容易上涨，这使得小规模医疗机构和经济困难的患者难以负担。这种价格敏感性限制了这些产品在新兴市场的渗透，并阻碍了它们在资源匮乏地区的普及和使用，最终影响患者获得这些重要医疗干预的机会。

经导管栓塞和闭塞装置的市场趋势

经导管栓塞和闭塞装置市场正经历着向非手术治疗方案的显着转变，这主要得益于患者和医疗服务提供者对微创手术的偏好。这一趋势凸显了人们对这些技术优势的日益认可，包括更少的併发症、更快的恢復时间和更低的手术风险。随着医疗保健向以患者为中心的模式发展，植入式装置作为传统开放性手术的可行替代方案的需求日益增长。这种转变不仅改善了治疗效果，也符合更广泛的医疗目标，使经导管栓塞和闭塞装置成为现代治疗策略的核心组成部分。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Boston Scientific Corporation（US）
Terumo Corporation（Japan）
Medtronic（Ireland）
Abbott（US）
Cook Medical Inc.（US）
Penumbra, Inc.（US）
Cerenovus（a subsidiary of Johnson & Johnson）（US）
Guerbet SA（France）
Merit Medical Systems, Inc.（US）
AngioDynamics, Inc.（US）
B. Braun Melsungen AG（Germany）
Humares（Germany）
Inari Medical, Inc.（US）
MicroVention, Inc.（US）
Endospan Ltd.（Israel）
Teleflex Incorporated（US）
Kaneka Corporation（Japan）
Abbott Vascular（a division of Abbott Laboratories）（US）
SentreHEART, Inc.（US）
Vascular Technologies（US）

简介目录

Product Code: SQMIG35A2295

Transcatheter Embolization and Occlusion Devices Market size was valued at USD 5.17 Billion in 2024 and is poised to grow from USD 5.54 Billion in 2025 to USD 9.67 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global market for transcatheter embolization and occlusion devices is evolving, driven by factors such as an aging population, favorable reimbursement policies, and growing insurance coverage, which enhance healthcare providers' adoption of these technologies. While regulatory challenges and competition pose hurdles, the market offers significant growth opportunities, particularly in addressing a diverse range of medical conditions. Emerging regions like Asia-Pacific and Africa present untapped potential for manufacturers, amplified by technological innovations in device design and imaging techniques. Collaborations among healthcare professionals, manufacturers, and research institutions foster advancements and market expansion. Furthermore, educating patients and healthcare providers on the advantages of minimally invasive treatments is crucial, as leveraging artificial intelligence and data analytics can enhance precision and personalization in medical management, driving further demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transcatheter Embolization and Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transcatheter Embolization and Occlusion Devices Market Segments Analysis

Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Transcatheter Embolization and Occlusion Devices Market

The rising prevalence of chronic illnesses, including cancer, liver disease, and cardiovascular disorders, is propelling the need for minimally invasive medical interventions like transcatheter embolization and occlusion (TEO) devices. These devices are particularly valuable in addressing cancer, which remains a major cause of mortality globally, especially in the case of hard-to-treat tumors. Embolization methods have gained recognition as effective palliative care options, prompting healthcare providers to incorporate TEO devices to enhance patient outcomes. This increasing adoption within medical facilities is significantly driving the growth of the transcatheter embolization and occlusion devices market.

Restraints in the Transcatheter Embolization and Occlusion Devices Market

The high costs associated with hemodialysis techniques and related equipment present a significant obstacle to the broader adoption of Transcatheter Embolization and Occlusion Devices, particularly in developing areas. The advanced nature of devices like drug-elution beads and radio-embolization kits contributes to their elevated prices, which can render them unaffordable for smaller healthcare providers and financially disadvantaged patients. This sensitivity to pricing limits the ability of these products to penetrate emerging markets, inhibiting their availability and use in regions where healthcare resources are limited, ultimately affecting patient access to these important medical interventions.

Market Trends of the Transcatheter Embolization and Occlusion Devices Market

The Transcatheter Embolization and Occlusion Devices market is witnessing a significant shift towards nonsurgical treatment options, driven by both patient and provider preferences for minimally invasive procedures. This trend highlights a growing recognition of the benefits associated with such techniques, including reduced complications, quicker recovery periods, and diminished surgical risks. As healthcare moves increasingly towards patient-centered care, the demand for implantable devices as viable alternatives to traditional open surgery is escalating. This shift not only enhances therapeutic outcomes but also aligns with broader healthcare goals, positioning TEO devices as pivotal components in contemporary treatment strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Patent Analysis
Regulatory Landscape
Top Investment Analysis
Key Success Factor
Degree of Competition

Transcatheter Embolization and Occlusion Devices Market byType

Market Overview
Coil
- Pushable Coils
- Detachable Coils
Non-Coil
- Flow Diverting Devices
- Embolization Particles
- Liquid Embolics
- Others

Transcatheter Embolization and Occlusion Devices Market byApplication

Market Overview
Peripheral Vascular Disease
- Arterial Blockage
- Venous Blood clot
- Others
Oncology
Neurology
- Brain Aneurysm
- Cerebral Arteriovenous Malformations
- Others
Urology
- Benign Prostatic Hyperplasia/Urinary Retention
- Others
- Varicocele
Others

Transcatheter Embolization and Occlusion Devices Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerenovus (a subsidiary of Johnson & Johnson) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Humares (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endospan Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Vascular (a division of Abbott Laboratories) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SentreHEART, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments